Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MannKind Corp (NASDAQ:MNKD)

5.42
Delayed Data
As of Oct 16
 +0.14 / +2.65%
Today’s Change
0.67
Today|||52-Week Range
6.96
+70.25%
Year-to-Date

Today’s Trading

Previous close5.28
Today’s open5.50
Day’s range5.38 - 5.72
Volume10,125,010
Average volume (3 months)5,387,132
Market cap$606.5M
Dividend yield--
Data as of 10/16/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-170.10%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratio3.7
Price/Sales1.68
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OCXOncoCyte Corp-0.35-5.22%
BDSIBioDelivery Sciences...-0.02-0.86%
OMEDOncoMed Pharmaceutic...-0.31-7.23%
CLSDClearside Biomedical...+0.03+0.39%
Data as of 10/16/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$174.8M
Annual profit (last year)$125.7M
Net profit margin71.91%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michael E. Castagna
Chief Financial Officer &
Chief Accounting Officer
Steven Binder
Corporate headquarters
Westlake Village, California

Forecasts